Envista(NVST) - 2023 Q2 - Earnings Call Presentation

Revenue Sales Adjusted Operating Margin ( $m)$ 245.4 $238.1 25.7% 21.7% − Restorative & Endodontics business grew strongly; Infection prevention − Continue to de-emphasize non-strategic solutions and geographies | --- | --- | --- | |-------------------------------|-------|-------| | Free Cash Flow** Summary ($ M) | Q2'22 | Q2'23 | | Operating cash flow* | $22.2 |$ 75.1 | | Capital expenditures, net* | $10.4 |$ 14.1 | | Free cash flow*,** | $11.8 |$ 61.0 | • Free Cash Flow 8 Core Sales Growth and Adjusted EBI ...